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Abstract
Nine neurodegenerative disorders, called polyglutamine (polyQ) diseases, are characterized by the formation of intranuclear
amyloid-like aggregates by nine proteins containing a polyQ tract above a threshold length. These insoluble aggregates
and/or some of their soluble precursors are thought to play a role in the pathogenesis. The mechanism by which polyQ
expansions trigger the aggregation of the relevant proteins remains, however, unclear. In this work, polyQ tracts of different
lengths were inserted into a solvent-exposed loop of the b-lactamase BlaP and the effects of these insertions on the
properties of BlaP were investigated by a range of biophysical techniques. The insertion of up to 79 glutamines does not
modify the structure of BlaP; it does, however, significantly destabilize the enzyme. The extent of destabilization is largely
independent of the polyQ length, allowing us to study independently the effects intrinsic to the polyQ length and those
related to the structural integrity of BlaP on the aggregating properties of the chimeras. Only chimeras with 55Q and 79Q
readily form amyloid-like fibrils; therefore, similarly to the proteins associated with diseases, there is a threshold number of
glutamines above which the chimeras aggregate into amyloid-like fibrils. Most importantly, the chimera containing 79Q
forms amyloid-like fibrils at the same rate whether BlaP is folded or not, whereas the 55Q chimera aggregates into amyloid-
like fibrils only if BlaP is unfolded. The threshold value for amyloid-like fibril formation depends, therefore, on the structural
integrity of the b-lactamase moiety and thus on the steric and/or conformational constraints applied to the polyQ tract.
These constraints have, however, no significant effect on the propensity of the 79Q tract to trigger fibril formation. These
results suggest that the influence of the protein context on the aggregating properties of polyQ disease-associated proteins
could be negligible when the latter contain particularly long polyQ tracts.
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Introduction
Polyglutamine (polyQ) diseases are neurodegenerative disorders
caused by the expansion of unstable CAG trinucleotide repeats in
the translated region of unrelated genes. These CAG repeats
encode a polyglutamine stretch in the corresponding proteins [1].
At least nine polyQ-related disorders are known including
Huntington’s disease and several spinocerebellar ataxias [1]. The
nine disease-associated proteins show no sequence or structural
similarity apart from the expanded polyQ tract which is located at
a different position in each protein. The polyQ tract appears,
therefore, to be a critical determinant of polyQ diseases and
several lines of evidence suggest that it confers a toxic function to
the mutant proteins [2,3]. Although the nine diseases present
distinct pathological and molecular phenotypes, they share a
number of common features, suggesting a common physiopath-
ological mechanism [4]. Firstly, there is a threshold in the number
of repeats above which polyQ proteins become pathogenic. The
value of this threshold varies from one disease to another but
generally resides between 35 and 45 glutamines [5]. Secondly,
above the threshold value, the longer the repeat, the earlier the
onset and more severe the disease; this phenomenon is known as
the ‘‘anticipation phenomenon’’ [4]. Thirdly, polyQ expansion
mediates the deposition of nuclear inclusion bodies that contain
amyloid-like fibrils [6]. Although the mechanism of toxicity
associated with pathological expansion of polyglutamine tracts
remains unclear, a large body of evidence indicates that it is
associated with protein misfolding and aggregation [7,8]. Thus,
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e31253the cytotoxicity of proteins containing an expanded polyQ tract
has been attributed to: (i) the formation of inclusion bodies [9,10],
(ii) the presence of misfolded protein monomers [11] and (iii) the
transient formation of oligomers during the aggregation process
[12,13,14].
Two major scenarios, which are not necessarily mutually
exclusive, have been put forward to explain how expanded polyQ
tracts promote the aggregation of proteins [5,15]. Firstly, it has
been suggested that long polyQ repeats (.36Q) have a high
intrinsic propensity to form ‘‘polar zippers’’ which consist of b-
sheets stabilized by hydrogen bonds between both main-chain and
side-chain amides [16]. The formation of such structures is
thought to trigger aggregation into amyloid fibrils. Alternatively,
expanded polyQ tracts have been suggested to destabilize the
proteins and thereby facilitate the formation of partially unfolded
species [17,18,19]. Such species generally expose at least part of
their main chain and hydrophobic residues to solvent and are
therefore prone to intermolecular interactions leading to fibril
formation. Such a mechanism has been described for other
proteins associated with amyloidosis, including transthyretin [20]
and human lysozyme [21,22].
Although the aggregation of polyQ proteins critically depends
on the expansion of the polyQ stretch above the pathological
threshold, it is however becoming increasingly evident that regions
outside the polyQ tract can modulate both the kinetics and the
pathway of aggregation [15,23]. The observation that the
aggregation threshold of polyQ peptides is significantly lower
($15Q) than that observed for the proteins associated with
diseases is a clear indication of the effects of the surrounding
sequences [16,24]. Another evidence was provided by Bhattachar-
yya and co-workers [23], who showed that the addition of ten
prolines at the C-terminal end of polyQ peptides decreased both
their rate of in vitro aggregation and the stability of the resulting
aggregates. The influence of the flanking sequences was also
observed in the context of different proteins [25,26,27].
Various mechanisms have been proposed to explain the
influence of the polyQ flanking regions on the aggregation
properties of polyQ proteins [5]. Host protein domains could
protect against aggregation by: (i) enhancing total protein solubility
[27,28,29], (ii) sterically hindering polyQ intermolecular interac-
tions and/or (iii) restricting the polyQ conformational changes
required for fibril formation [23,30]. On the other hand, host
protein domains adjacent to the polyQ tract can assist aggregation
by providing additional aggregation-prone regions. There is
indeed experimental evidence that at least ataxin-3 and the first
exon of huntingtin (Htt exon 1) form fibrillar aggregates via a
complex multidomain mechanism initiated by intermolecular
interactions within non-polyQ regions of the protein. Although
the polyQ region is not directly involved in this step, it does
indirectly modulate the aggregation propensity of the non-polyQ
region through a mechanism that is yet to be fully understood. It
possibly involves the destabilization of the non-polyQ region and/
or changes in its structure or dynamics [19,31]. At later stages, the
expanded polyQ tract is then directly involved in the formation of
the core of mature fibrils [17,19,32].
Taken together, these results highlight the existence of a
complex interplay between the intrinsic properties of the polyQ
tract to trigger aggregation and the modulating effects of the host
protein. To gain a better insight into the general principles
governing this complex phenomenon, it is necessary to investigate
in detail which properties of the host protein influence the ability
of polyQ stretches to mediate aggregation; this is therefore the
subject of intensive research [17,19,23,30,32–37]. The difficulty in
handling proteins involved in diseases, essentially due to their large
size and insoluble character, has prompted the design and use of
model proteins [11,18,25,31,34,35,37–40]. The characterization
of these proteins unambiguously points to the length and the
location of the polyQ tract as important factors [18,34,35,37]. A
number of questions are, however, not yet fully addressed; these
include the role of the sequence, size, structure, stability, dynamics
and topology of the host protein. There is therefore a clear need
for the generation of new model polyQ proteins of various sizes,
topologies and structures and the extensive characterization of
their structural, thermodynamic, dynamic and aggregating
properties.
In proteins associated with polyQ diseases, the polyQ tract is
separated from the C- or N-terminal ends by at least 50 residues,
except for the proteins associated with Hungtinton’s disease (HD,
17 residues) and spinocerebellar ataxia type 6 (SCA6, 30 residues)
[34]. Many model proteins characterized so far, however, display
a polyQ tract fused to their N- or C-terminus [35,37,39,41],
probably because polypeptide chains with an inserted polyQ
sequence are difficult to express [35,37]. It is therefore essential to
investigate more model proteins containing an inserted polyQ
stretch since the presence of flanking sequences at both extremities
of the polyQ tract is likely to impose constraints that are more
physiologically relevant than when the polyQ tract has a free
extremity. With this aim in mind, we inserted polyQ sequences of
various lengths into a solvent-exposed loop of a well-characterized
globular protein, and we investigated the effects of these insertions
on its structure, stability and aggregating properties.
The b-lactamase from Bacillus licheniformis 749/C (BlaP) was
used as the protein scaffold. This 264-residue enzyme is organized
into two structural domains, with the active site located at the
interface of the two domains (Figure 1A) [42]. We chose this
scaffold for several reasons: (i) detailed information concerning its
thermodynamic and catalytic properties are available [43,44],
providing a strong basis to investigate the effects of polyQ
insertions, (ii) the solvent-exposed loop located between helices 8
and 9 (the position 197–198, Figure 1A) has been clearly shown to
tolerate amino acid insertion [44,45], and (iii) chimeras with
inserts of various lengths and structures can be readily produced in
Escherichia coli ([44,45] and unpublished results).
We have created and characterized a series of chimeras with 23,
30, 55 and 79 glutamines inserted at position 197–198 (Figure 1A
and B) using a range of biophysical techniques including
fluorescence, circular dichroism (CD), transmission electron
microscopy (TEM) and X-ray diffraction. We have found that
the insertion of a polyQ tract consisting of up to 79 residues does
not modify the structure of the enzyme, although it significantly
reduces its conformational stability. The results of this study also
show that the aggregating properties of the chimeras are similar to
those of proteins associated with polyQ diseases. Thus, we
observed a threshold number of inserted glutamines above which
the chimeric b-lactamase aggregates into amyloid-like fibrils and
that the kinetics of aggregation are faster with longer glutamine
repeats. Most importantly, this work clearly demonstrates that the
threshold number of glutamines above which the chimeric
proteins aggregate into amyloid-like fibrils critically depends on
the structural integrity of the b-lactamase moiety and thus on the
constraints applied to the polyQ tract. It also suggests that the
modulating effects of the protein context on the aggregating
properties of proteins associated with polyQ diseases could be
negligible when the latter contain particularly long polyQ tracts.
Finally, our results indicate that BlaP is a promising scaffold for
further investigation of the delicate balance between the
propensity of polyQ tracts to trigger aggregation and the
modulating effects of the host proteins.
Effects of PolyQ Tracts on the Properties of BlaP
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Production of the chimeras
Four expression vectors encoding for chimeric b-lactamases
containing 23, 30, 55 and 79 glutamines [BlaP(Gln)23, BlaP(Gln)30,
BlaP(Gln)55 and BlaP(Gln)79, respectively] were constructed as
described in the Materials and Methods, by inserting CAG repeats
into a SmaI restriction site incorporated into the BlaP gene
between codons for residues 197 and 198. The introduction of this
SmaI restriction site adds a dipeptide proline-glycine to the
sequence of BlaP; the polyglutamine tract was inserted between
these two amino acids (Figure 1B). The proteins were produced in
E. coli and purified to homogeneity in one step using a Ni-PDC
affinity column. This procedure led to about the same amount (i.e.
10–20 mg per liter of culture) of the different proteins, irrespective
of the presence or absence of a polyQ tract. The purity of all
samples was .95% as assessed by SDS-PAGE (Figure 2A).
Although BlaP, BlaP(Gln)23 and BlaP(Gln)30 migrated at positions
expected, according to the molecular mass markers, chimeras with
either 55 or 79 glutamines showed lower mobility and thus, greater
apparent molecular masses than expected. Such anomalous
behaviour, which was also observed for chimeras composed of
myoglobin and polyQ tracts [40], suggests that long polyQ
sequences interfere with SDS binding. The integrity of the proteins
was checked by mass spectrometry (ESI-QTOF-MS). This analysis
revealed the presence of three distinct peaks in the spectrum of
each protein. Although in all cases, the main peak (estimated at
.70% of the population) corresponds to the theoretical mass
deduced from the complete amino acid sequence, the two other
peaks correspond to higher molecular mass species, i.e. +182 Da
(10–20% of the population) and +200 Da (,10% of the
population). N-terminal sequencing indicated that the main peak
corresponds to the enzyme with a well-processed N- terminal
sequence (T-E-M-K) (Figure 1B), whereas the peak at +200 Da
corresponds to the full-length protein plus the last two residues of
the signal peptide (Q-A-T-E-M-K). The same N-terminal
misprocessing was also observed for another BlaP chimera [44].
The nature of the +182 Da adduct is not clear. Since the
proportion of each molecular species is similar between various
protein preparations, it is assumed that they do not interfere with
the main conclusions of this work.
Size-exclusion chromatography (SEC) analysis of protein
preparations at high concentrations (50 mM and 120 mM) revealed
that all proteins, particularly BlaP, form dimers although in small
amount (at 120 mM, 5.6% for BlaP and ,1.5% for the four
chimeras, Table 1). Minute quantities of high molecular weight
species were also observed in BlaP(Gln)79 solution (3.5% at
120 mM and 2.5% at 50 mM) (Table 1 and Figure 2B). Based on
their volume of elution and assuming that these oligomeric species
are spherical, their apparent molecular mass can be estimated to
be higher than 600 kDa, and thus formed by 15 or more
Figure 2. Purification of BlaP and the chimeras. (A) Purified BlaP
and polyQ-containing chimeras separated on a 15% (w/v) SDS-
polyacrylamide gel and stained with coomassie blue. First lane on the
left shows protein markers with molecular masses as indicated, whereas
the other lanes show BlaP and the various chimeric proteins as
indicated. Expected molecular masses are 30 368, 33 315, 34 212,
37 416 and 40 491 Da for BlaP and chimeras with 23, 30, 55 and 79
glutamines, respectively. (B) SEC analysis of BlaP(Gln)79 at 120 mMi n
PBS, pH 7.5; mAU, milli-absorbance units. Monomeric, dimeric and high
molecular weight species are indicated by black, grey and white arrows,
respectively. The high molecular weight oligomeric species are eluted in
the void volume of the column.
doi:10.1371/journal.pone.0031253.g002
Figure 1. X-ray structure and topology of the host protein BlaP.
(A) The structure of BlaP was produced using PyMOL (DeLano Scientific
LLC, South San Francisco, CA, USA) and the PDB ID is 4BLM [42]. The
active site serine (Ser70) is indicated by a star and the insertion site is
shown by an arrow. (B) Topology of BlaP. The position 197–198 of the
insertion site refers to the numbering scheme of class A b-lactamases
[65]. The underlined PG dipeptide between residues 197 and 198
corresponds to the SmaI restriction site inserted into the gene of BlaP
for the cloning of CAG repeats.
doi:10.1371/journal.pone.0031253.g001
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from 50 mMt o1 0mM reduces the percentage of these oligomeric
species to less than 2% (Table 1). Following the observation that in
all cases more than 95% of the protein population is monomeric at
concentrations as high as 50 mM, we assumed that the presence of
dimers and oligomers did not interfere with the determination of
the catalytic and thermodynamic parameters which were carried
out with protein concentrations #4.6 mM.
The polyQ tract adopts a disordered structure and does
not perturb the overall structure of BlaP
The effects of the insertion of polyQ tracts of 23, 30, 55 and 79
residues on the structure of BlaP were investigated by intrinsic
fluorescence and CD measurements. Fluorescence and near-UV
CD data (Figure 3A and B) suggest that none of the polyQ
insertions into the loop between the a-helices 8 and 9 of BlaP
significantly affects the tertiary structure of the protein. This is
further supported by the observation that insertion of polyQ
sequences of various lengths does not significantly modify the
catalytic properties of the b-lactamase (Table 2). In contrast, the
far-UV CD spectra of the chimeras show marked differences with
that of the wild-type protein (Figure 3C). Subtraction of the BlaP
Table 1. Percentages of the different species observed by
SEC.
[protein] (mM) M (%) D (%) O (%)
BlaP 50 95.1 4.9 0
120 94.4 5.6 0
BlaP(Gln)23 50 99.4 0.6 0
120 99.3 0.7 0
BlaP(Gln)30 50 99.6 0.4 0
120 99.5 0.5 0
BlaP(Gln)55 50 98.9 1.1 0
120 98.6 1.4 0
BlaP(Gln)79 10 97.3 0.9 1.8
50 96.4 1.1 2.5
120 95.3 1.2 3.5
This analysis was carried out using a Superdex 200 GL 10/300 column using PBS
buffer, pH 7.5. M, D, O stand for monomeric, dimeric, and high molecular
weight oligomeric species, respectively.
doi:10.1371/journal.pone.0031253.t001
Figure 3. PolyQ insertions have no effect on the structure of BlaP. (A) Intrinsic fluorescence, (B) near-UV CD and (C) far-UV CD spectra of BlaP
(blue) and the chimeras with 23 (red), 30 (green), 55 (pink) and 79 (cyan) glutamines. a.u., arbitrary units. (D) Difference spectra obtained by
subtraction of the far-UV CD spectrum of BlaP from that of each chimeric protein. Spectra were recorded at 25uC in PBS, pH 7.5, using protein
concentrations of 4.6 mM (fluorescence and far-UV CD) and 20 mM (near-UV CD).
doi:10.1371/journal.pone.0031253.g003
Effects of PolyQ Tracts on the Properties of BlaP
PLoS ONE | www.plosone.org 4 March 2012 | Volume 7 | Issue 3 | e31253spectrum from the spectra of the chimeras gives an indication of
the structure adopted by the polyQ insert. Interestingly, the
difference spectra display a negative peak with a minimum at ca.
202–203 nm, the amplitude of which increases with the number of
glutamines (Figure 3D). This result suggests that the polyQ tract: (i)
does not significantly modify the secondary structure of BlaP and
(ii) adopts a disordered structure at the surface of the protein
irrespective of the number of glutamines.
A similar absence of structural modification of the non-polyQ
regions was observed when a polyQ tract is fused to the B domain
of the protein A from Staphylococcus aureus (SpA) or apomyoglobin
[35,37]; however, radically different results were reported for
inserted polyQ tracts. The most characterized chimeric proteins
with inserted polyQ sequences were created from three all-a
proteins: myoglobin [18], SpA [35] and apomyoglobin [37]. In
these model proteins, the polyQ tract was inserted into a loop
between a-helices. The insertion of a polyQ tract into either
myoglobin [18] or SpA [35] induces changes in the tertiary
structure of the host proteins, with no significant effect on their
secondary structure. The insertion of at least 16Q in apomyoglo-
bin leads, however, to significant changes in secondary structure,
besides a polyQ length-independent loss of tertiary structure [37].
This partial loss of structure was also observed when serine-glycine
repeats were inserted at the same location, suggesting that it was
not specific to polyQ insertion. As a likely consequence of these
structural changes, the production yield for at least two of these
model proteins was significantly lower than that of their respective
wild-type counterparts, and this was shown to be directly related to
the length of the polyQ tract inserted [35,37]. To date, the model
protein with the longest inserted polyQ sequence reported in the
literature consists of a chimeric myoglobin containing 50
glutamines only [18]. In contrast, the production yield of our
BlaP chimeras remains unchanged (i.e. 10–20 mg per liter of
culture), even when a 79-glutamine sequence is inserted at position
197–198. This makes BlaP an ideal scaffold to investigate the
effects of long inserted polyQ sequences.
Our CD data suggest that the polyQ tracts of 23-79Q, inserted
into the solvent-exposed loop of BlaP, adopt a disordered
structure. This observation is in very good agreement with the
results obtained with other model proteins containing variable-
length polyQ tracts, e.g. (i) polyQ sequences fused either to SpA or
GST [35,39,41] and (ii) the exon 1 of huntingtin fused to
thioredoxin [38]. In contrast, data obtained with myoglobin and
apomyoglobin indicated that inserted polyQ sequences of
sufficient length (ca. 16-28Q) could form b-structures [18,37].
These findings suggest that the conformation adopted by a polyQ
stretch is strongly context-dependent. The observation that a 79-
residue long polyQ sequence is disordered when inserted into
BlaP, suggests that it does not adopt any stable, aggregation-prone,
b-sheet structure in solution prior to aggregation into amyloid-like
fibrils. Because of the low sensitivity of the structural techniques
used in this work, we cannot exclude, however, the possibility that
the polyQ tract might rarely and/or transiently access more
organized structures.
The polyQ tract destabilizes BlaP and the extent of
destabilization is largely independent of the polyQ
length
The effects of polyQ insertions of different lengths (23, 30, 55
and 79Q) on the stability of BlaP were determined by urea-
induced unfolding experiments. For each protein, unfolding was
found to be fully thermodynamically reversible (data not shown)
and single transitions were observed (Figure 4A). The data
obtained by intrinsic fluorescence and far-UV CD coincide,
indicating that the five proteins unfold according to a simple two-
state mechanism, with no intermediate species significantly
populated between the native and unfolded states. Based on this
model, the characteristic thermodynamic parameters were deter-
mined and are given in Table 3. These data show that all four
chimeras are destabilized with respect to the wild-type protein.
Remarkably, the extent of destabilization is similar, i.e. 7.6–
8.8 kJ?mol
21, for all four chimeric proteins and thus is largely
independent of the length of the polyQ stretch. Thermal unfolding
of BlaP and its chimeras (Figure 4B) was also monitored by both
intrinsic fluorescence and far-UV CD measurements. Although
this process was not reversible (data not shown), cooperative
transitions were observed and apparent temperatures of mid-
transition (Tm
app) were determined (Table 3). In good agreement
with urea-unfolding data, all chimeras are less stable than the wild-
type protein (DTm
app=4.5–5.3uC) and the extent of destabiliza-
tion is independent of the number of glutamines.
The fact that the extent of BlaP destabilization is independent of
the number of glutamines contrasts with observations on other
model systems reporting: (i) no destabilization at all, e.g. the
protein moeity SpA when fused to a polyQ tract up to 52 residues
in length [35], (ii) selective destabilization, e.g. the cellular retinoic
acid binding protein I (CRABP I) moiety when fused to Htt exon 1
containing polyQ stretches longer than a threshold size [31], (iii)
cumulative destabilization, e.g. chymotrypsin inhibitor 2 (CI2)
[46], myoglobin [18] and SpA [35] containing inserted polyQ
tracts, where the extent of destabilization increases with increasing
polyQ length, independently of a threshold. Finally, a polyQ-
length independent destabilization was also described for apo-
myoglobin containing an inserted polyQ tract [37] but this effect
does not seem specific to the glutamines, since a similar
destabilization was observed when serine-glycine repeats were
inserted at the same location. In the case of BlaP, insertion of the
73-residue long chitin-binding domain of human macrophage
chitotriosidase [44] destabilizes the host protein significantly less
than the polyQ tracts (i.e. 3.2 kJ?mol
21 vs 7.6–8.8 kJ?mol
21). This
suggests that the extent of destabilization of BlaP depends more on
the nature of the polypeptide inserted than its length, and that the
insertion of the disordered polyQ stretch is more destabilizing than
that of the folded chitin-binding domain of human macrophage
chitotriosidase. Taken together, these data show that the effects of
polyQ insertion on the stability of the host protein vary greatly
depending on the properties of the latter.
The observation that the chimeric b-lactamases with 30, 55 and
79 glutamines are destabilized to the same extent relative to wild-
type BlaP (Table 3) gave us the unique opportunity to investigate
independently the influence of (i) the length of the polyQ sequence
and (ii) the conformational state of the b-lactamase moiety on the
aggregating properties of the chimeras. Accordingly, the aggre-
Table 2. Kinetic parameter values for the wild-type and
chimeric b-lactamases.
kcat (s
21)K m (mM) 10
266kcat/Km (M
21?s
21)
BlaP 90610 25633 . 6 60.4
BlaP(Gln)23 120610 32643 . 7 60.3
BlaP(Gln)30 87672 7 633 . 1 60.2
BlaP(Gln)55 107610 31633 . 5 60.5
BlaP(Gln)79 77622 7 622 . 9 60.1
Cephalothin was used as the substrate. Errors are given as standard deviations.
doi:10.1371/journal.pone.0031253.t002
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investigated under both native and denaturing conditions.
The threshold length of the polyQ tract above which
chimeras aggregate into amyloid-like fibrils depends on
the structural integrity of BlaP
Aggregation under denaturing conditions. The aggregating
properties of the proteins were first investigated in the presence of
1.85 M urea (in PBS, pH 7.5), at 25uC. Data in Figure 4A and
Table 3 indicate that under these conditions, all BlaP molecules are
native, whereas ca. 18% and 50% of the molecules of, respectively,
BlaP(Gln)23 and the three other chimeric enzymes, are unfolded.
The kinetics of aggregation were monitored by measuring the
amount of protein that remained soluble after different incubation
times. BlaP, BlaP(Gln)23 and BlaP(Gln)30 display little, if any,
tendency to aggregate, even after ca. 720 hours of incubation,
whereas both BlaP(Gln)55 and BlaP(Gln)79 readily aggregate
(Figure 5A). Aggregation of BlaP(Gln)55 is characterized by a lag
phase (ca. 50 hours) while very fast aggregation with no discernable
lag phase is observed with BlaP(Gln)79. The lag phase is consistent
with the nucleation-polymerization mechanism that has been
proposed for amyloid fibril formation [47] and corresponds to the
Figure 4. PolyQ insertions destabilize BlaP and the extent of destabilization is largely independent of the polyQ length. (A)
Normalized urea-induced unfolding transitions at pH 7.5 and 25uC and (B) normalized heat-induced unfolding transitions at pH 7.5, monitored by the
changes in fluorescence intensity at 323 nm (filled circles) and in ellipticty at 222 nm (open circles), using a protein concentration of 4.6 mM. BlaP
(blue), BlaP(Gln)23 (red), BlaP(Gln)30 (green), BlaP(Gln)55 (pink) and BlaP(Gln)79 (cyan). Non-normalized data were analysed on the basis of a two-state
model and the values of the thermodynamic parameters obtained are reported in Table 3.
doi:10.1371/journal.pone.0031253.g004
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fibrillar aggregates (Figure 5C) are clearly visible by TEM for
BlaP(Gln)55 and BlaP(Gln)79, respectively. In contrast, even after
720 hours of incubation, only minute amounts of amorphous
aggregates, but no fibrils, were observed with BlaP, BlaP(Gln)23 and
BlaP(Gln)30 (Figure 5C). The aggregates formed by BlaP(Gln)55 and
Table 3. Thermodynamic parameter values of unfolding of wild-type and chimeric BlaP.
DG6NU(H2O) (kJ?mol
21) 2mNU (kJ?mol
21?M
21)C m (M) Tm
app (6C)
BlaP 37.061.8 13.560.6 2.7460.23 58.560.4
BlaP(Gln)23 29.362.4 13.760.9 2.1360.19 53.960.7
BlaP(Gln)30 29.461.2 15.960.7 1.8560.15 53.760.3
BlaP(Gln)55 29.060.6 15.660.6 1.8660.15 53.560.6
BlaP(Gln)79 28.261.3 14.960.6 1.8960.17 53.260.3
The values were deduced from the analysis of unfolding transitions monitored by intrinsic fluorescence and far-UV CD measurements. The urea unfolding experiments
were carried out at 25uC. DG6NU(H2O), mNU, Cm and Tm
app values result from the mean of the values obtained by far-UV CD and intrinsic fluorescence; note that for
thermal unfolding, three measurements were carried out both by fluorescence and CD. Thermal unfolding was not fully reversible and only the apparent mid-unfolding
temperature (Tm
app) was determined.
doi:10.1371/journal.pone.0031253.t003
Figure 5. Only BlaP(Gln)55 and BlaP(Gln)79 form amyloid-like fibrils when incubated in the presence of 1.85 M urea. (A) Aggregation
kinetics of 110 mM BlaP (blue), BlaP(Gln)23 (red), BlaP(Gln)30 (green), BlaP(Gln)55 (pink) and BlaP(Gln)79 (cyan) at 25uC in the presence of 1.85 M urea in
PBS, pH 7.5, followed by measuring the concentration of protein remaining soluble. Time-points shown with an error bar are the average of three
independent time-courses for BlaP(Gln)30, BlaP(Gln)55 and BlaP(Gln)79 and two independent time-courses for BlaP. Error bars show the standard
deviations. Only one time-course was carried out with BlaP(Gln)23.( B) ThT fluorescence intensities at 482 nm in the presence of BlaP and chimeras
samples at T0 (solid bars) and Tf (dashed bars). T0 and Tf correspond to the initial and final points of one time-course for each protein. Data are the
average of three measurements and error bars represent the standard deviations. a.u., arbitrary units. (C) TEM images of the protein samples at Tf. The
scale bar is 1 mm. (D) X-ray fibre diffraction patterns from BlaP(Gln)55 and BlaP(Gln)79 fibrils. White and black arrows indicate meridional and equatorial
reflections at 4.7 A ˚ and ca. 9.5 A ˚, respectively.
doi:10.1371/journal.pone.0031253.g005
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significantly bind ThT (Figure 5B), suggesting that the fibrils
observed are amyloid-like. The degree of ThT binding observed
for BlaP(Gln)79is,however,significantlylowerthanthatobserved for
BlaP(Gln)55, a surprising observation considering that BlaP(Gln)79
aggregates to a higher extent than its 55-glutamine homolog
(Figure 5A). The significantly lower ThT binding to BlaP(Gln)79
fibrils may be due to an alternative overall packing of the aggregates.
This is consistent with the observation that aggregates formed by
BlaP(Gln)79were clearly larger and more difficultto resuspend in the
ThT solution. For BlaP(Gln)79, the ThT fluorescence measurements
were performed with samples incubated for ca. 330 hours and since
the protein is fully aggregated after 100 hours, the aggregates could
mature (e.g. laterally associate) during the last 200 hours of
incubation. In the case of BlaP(Gln)55, the aggregation is much
slower and there is therefore less time for fibril maturation until the
final point of the time-course (i.e. when samples were taken for ThT
fluorescence measurements at ca. 720 hours) (Figure 5A). Aggregates
formedbyBlaP(Gln)55and BlaP(Gln)79wereanalyzedbyX-rayfibre
diffraction. Both diffraction patterns obtained show two reflections: a
sharp meridional one at 4.7 A ˚ and a broad and more diffuse
equatorial one at ca. 9.5 A ˚ (Figure 5D). Despite difficulties
encountered in aligning the fibrils, these reflections are consistent
with a cross-b structure characteristic of amyloid fibrils and reflect
the distance between the b-strands in each sheet of the amyloid
protofilament (4.7 A ˚) and the spacing between the b-sheets (ca.
9.5 A ˚)[ 4 8 ] .
These results show that, although the three chimeras
BlaP(Gln)30, BlaP(Gln)55 and BlaP(Gln)79 are equally destabilized
under the conditions used to monitor aggregation (i.e. 50% of the
molecules of each protein are unfolded at 25uC in the presence of
1.85 M urea), only those with 55 and 79 glutamines significantly
Figure 6. The unfolding of the b-lactamase moiety is not the critical factor that triggers the aggregation process. (A) Aggregation
kinetics of 110 mM BlaP (blue), BlaP(Gln)23 (red), BlaP(Gln)30 (green), BlaP(Gln)55 (pink) and BlaP(Gln)79 (cyan) at 25uC in the presence of 3.5 M urea in
PBS, pH 7.5, followed by measuring the concentration of protein remaining soluble. Time-points shown with an error bar are the average of three
independent time-courses for BlaP(Gln)55 and BlaP(Gln)79. Error bars show the standard deviations. For BlaP, two independent experiments were
carried out (filled and open blue circles); however, since the times at which samples were taken differ from one time-course to the other, the data
could not be averaged. For BlaP(Gln)23 and BlaP(Gln)30, only one time-course was carried out. (B) ThT fluorescence intensities at 482 nm in the
presence of BlaP and chimeras samples at T0 (solid bars) and Tf (dashed bars). T0 and Tf correspond to the initial and final points of one time-course
for each protein. Data are the average of three measurements and error bars represent the standard deviations. a.u., arbitrary units. (C) TEM images of
the protein samples at Tf. The scale bar is 1 mm. (D) X-ray fibre diffraction patterns from BlaP(Gln)55 and BlaP(Gln)79 fibrils. White and black arrows
indicate meridional and equatorial reflections at 4.7 A ˚ and ca. 9.5 A ˚, respectively.
doi:10.1371/journal.pone.0031253.g006
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experiment. Hence, independently of the extent of destabilization,
there seems to be a minimal length (i.e. a threshold) of the polyQ
tract beyond which chimeric b-lactamases readily aggregate. This
value is comprised between 30 and 55 residues, which is
reminiscent of the threshold number of glutamines above which
other model proteins fused to a polyQ tract aggregate both in vivo
and in vitro [31,49] and, more importantly, of the pathological
threshold observed in polyQ diseases [5].
BlaP and all the chimeras (with 23 to 79Q) were also incubated
at 25uC in the presence of 3.5 M urea, a concentration at which all
proteins are unfolded (Figure 4A). Under these conditions, again,
only BlaP(Gln)55 and BlaP(Gln)79 noticeably aggregate into fibrils
that possess characteristics of amyloid such as ThT binding and
cross-b structure (Figure 6A–D). Although BlaP, BlaP(Gln)23 and
BlaP(Gln)30 remain soluble, small amounts of amorphous
aggregates are observed by TEM for these proteins; these
aggregates do not bind ThT (Figure 6A–C).
Taken together, the results of these two experiments give a clear
indication that the unfolding of the b-lactamase moiety is not the
driving force underlying the fibrillar aggregation. Rather, it is
purely the expansion of the polyQ tract above a threshold length
that promotes the formation of amyloid-like fibrils. Moreover, in
the presence of 1.85 M or 3.5 M urea, the chimera with 79
glutamines aggregates faster than that containing 55 glutamines.
Such a polyQ length-dependent rate of aggregation has been
observed in all in vitro studies of polyQ peptides [23,50] and
different protein systems [31,35], and can be related to the so
called ‘‘anticipation phenomenon’’ characteristic of polyQ diseases
[4].
Aggregation under native conditions. Finally, the kinetics
of aggregation of BlaP, BlaP(Gln)55 and BlaP(Gln)79 were
monitored under conditions favouring the native state (PBS,
pH 7.5, 37uC) (Figure 4B). As observed under denaturing
conditions (Figures 5 and 6), only chimeras with 55 and 79
glutamines aggregate, whereas BlaP remains soluble throughout
the duration of the experiment (Figure 7A). The kinetics of
aggregation of BlaP(Gln)79 was similar to that obtained in the
presence of urea (Figures 5A and 6A) and the aggregates formed
significantly bind ThT (Figure 7B), display a fibrillar morphology
(Figure 7C), and exhibit a X-ray fibre diffraction pattern consistent
with a cross-b structure (Figure 7D). These observations are all
indicative of amyloid-like fibril formation by BlaP(Gln)79 under
native conditions. In contrast, BlaP(Gln)55 aggregates to a lesser
extent than in the presence of 1.85 M urea, and the resulting
species bind ThT only weakly (Figure 7B) and appear amorphous
when viewed by TEM (Figure 7C). These aggregates did not
mature into amyloid-like fibrils upon further incubation of up to
1500 hours (data not shown). Similarly, only small, disperse and
amorphous aggregates that do not bind ThT are visible by TEM
in BlaP samples at the end of the experiment (Figure 7B and C).
These results show that under native conditions, only the chimeric
b-lactamase with 79 glutamines forms amyloid-like fibrils. Our
data also show that under native conditions, the polyQ threshold
Figure 7. Only BlaP(Gln)79 form amyloid-like fibrils when incubated under native conditions. (A) Aggregation kinetics of 110 mM BlaP
(blue), BlaP(Gln)55 (pink) and BlaP(Gln)79 (cyan) at 37uC in PBS, pH 7.5, followed by measuring the concentration of protein remaining soluble. Time-
points shown with an error bar are the average of three independent time-courses for BlaP(Gln)55 and BlaP(Gln)79 and two independent time-courses
for BlaP. Error bars show the standard deviations. (B) ThT fluorescence intensities at 482 nm in the presence of BlaP and chimeras samples at T0 (solid
bars) and Tf (dashed bars). T0 and Tf correspond to the initial and final points of one time-course for each protein. Data are the average of three
measurements and error bars represent the standard deviations. ThT fluorescence intensities in the presence of BlaP samples are weak and for more
visibility, error bars (which are equal or less than to 0.3) are not shown. a.u., arbitrary units. (C) TEM images of the protein samples at Tf. The scale bar
is 1 mm. (D) X-ray fibre diffraction pattern from BlaP(Gln)79 fibrils at Tf. White and black arrows indicate meridional and equatorial reflections at 4.7 A ˚
and ca. 9.5 A ˚, respectively.
doi:10.1371/journal.pone.0031253.g007
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observed under denaturing conditions, suggesting that its value
depends on the structural integrity of the b-lactamase moiety.
Indeed, BlaP(Gln)55 is only able to form amyloid-like aggregates
when BlaP is unfolded (Figure 8A) whereas, remarkably,
BlaP(Gln)79 aggregates into amyloid-like fibrils at the same rate
irrespective of the incubation conditions and therefore, of the
conformational state (i.e. native or unfolded) of BlaP (Figure 8B).
This observation shows that the presence of folded BlaP suppresses
the intrinsic propensity of the 55-glutamine tract to trigger the self-
association of the chimera into amyloid-like fibrils. In other words,
in the presence of 55Q, the protective role of BlaP in polyQ-driven
aggregation into amyloid-like fibrils depends on the integrity of the
BlaP structure. In contrast, the conformational state of BlaP has no
discernable effect on the ability of the 79-glutamine tract to
promote the formation of amyloid-like fibrils.
The dependence of BlaP(Gln)55 aggregation on the structural
integrity of BlaP can result from both steric and conformational
constraints. The folded b-lactamase moiety may limit the
accessibility of the 55-glutamine tract via steric hindrances and
thus abrogate its propensity to form the highly ordered
intermolecular b-sheets characteristic of amyloid fibrils. The 55-
glutamine tract in the presence of folded BlaP leads, nevertheless,
to less organized intermolecular interactions and thus to the
Figure 8. The ability of BlaP(Gln)79 to form amyloid-like fibrils does not depend on the structural integrity of BlaP. Comparison
between the aggregation kinetics and the morphology of aggregates obtained with BlaP(Gln)55 (A) and BlaP(Gln)79 (B) under the following
conditions of incubation: (i) PBS, pH 7.5 and 0 M urea at 37uC (pink), (ii) PBS, pH 7.5 and 1.85 M urea at 25uC (blue) and (iii) PBS, pH 7.5 and 3.5 M
urea at 25uC (green). N is the native state and U is the unfolded state. The data correspond to those shown in Figures 5, 6, 7 without error bars.
doi:10.1371/journal.pone.0031253.g008
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however render the 55Q tract more accessible and thus permits
the formation of amyloid-like fibrils. In contrast, when expanded
to 79 glutamines, the polyQ tract is similarly accessible to interact
with other monomers to form amyloid-like fibrils whether BlaP is
denatured or not. The need to unfold BlaP in order to generate
amyloid-like fibrils from the 55Q chimera is reminiscent of that of
proteolysis observed with some proteins associated with polyQ
diseases. For example, nuclear inclusions from HD patients have
been shown to contain Htt fragments including the expanded
polyQ tract rather than the full-length protein [51]. It has been
proposed that these fragments have a higher tendency to self-
associate and thus may be crucial to initiate the aggregation
phenomenon [28,29]. Their greater propensity to aggregate is
probably due to the removal by proteolysis of some of the steric
hindrances otherwise exerted by the non-polyQ domains.
The protective effects mediated by the folded state of BlaP could
also be due to the imposition of some conformational constraints
on the polyQ tract. In a similar vein of what has been suggested by
a number of experimental and computational studies
[23,52,53,54], we propose that the polyQ tract which extends
from the solvent-exposed loop in BlaP exists as an ensemble of
heterogeneous disordered conformations, in dynamic equilibrium
with rare more structured conformational species, some of which
are competent for amyloid fibril formation. The longer the polyQ
repeat, the more dynamic it is and the wider the conformational
space it can sample. As a consequence, more aggregation-prone
conformations can be transiently sampled by longer polyQ tracts,
thus explaining their higher propensity to aggregate. The length-
dependent frequency at which the amyloid-competent conforma-
tions are visited, and thus the propensity of the polyQ tract to
aggregate into amyloid-like fibrils, is further modulated by the
conformational state of the b-lactamase moiety. Short polyQ
stretches (#30 residues) rarely or never access amyloid-competent
conformations, even if the b-lactamase is in its unfolded state. In
contrast, such conformations are equally sampled by the long
polyQ tracts ($79 residues) regardless of whether BlaP is native or
unfolded. Finally, for polyQ stretches of intermediate lengths (i.e.
30–79 residues), the frequency at which amyloid-competent
conformations are adopted critically depends on the structural
integrity of BlaP. For instance, the presence of folded BlaP
prevents the 55-glutamine tract from accessing conformational
precursors to amyloid-like fibril formation. Conversely, the
unfolding of the b-lactamase moiety would allow the 55-
glutamine tract to interconvert more freely between various
conformations and hence access, more frequently, conformations
that are competent for amyloid-like fibril formation. The
probability of accessing these conformations is however lower
for the 55- than the 79-glutamine tract, and thus a lag phase is
observed for BlaP(Gln)55 fibril formation. These results are
consistent with previous reports showing the importance of the
constraints imposed by adjacent sequences on the polyQ tract
[23,30]. For example, it was reported that the C-terminal
addition of 10 or 11 prolines to polyQ peptides tends to decrease
both aggregation rate and aggregate stability, and increases the
threshold for fibril formation by disfavoring aggregation-compe-
tent conformations [23,30]. The study of Darnell et al. strongly
suggests that it is the formation of constraining polyproline type II
helices by the C-terminal prolines that tips the balance in favor of
aggregation-incompetent conformations [30]. Moreover, a recent
study has shown that when a polyQ tract of pathological length is
positioned between two SpA domains, it triggers slower
aggregation than when it is located at the N-terminus of one
SpA domain [34]. The authors proposed that the reduction of the
aggregation rate is due to lower conformational freedom and
higher steric constraints.
Results obtained for the other model proteins with an inserted
polyQ tract can tentatively be analyzed in terms of the balance
between the intrinsic propensity of polyQ tracts to trigger
aggregation into amyloid-like fibrils and the constraints imposed
by the host protein on the polyQ tract. It is interesting to note that
the chimera of myoglobin containing 50Q aggregates into
amyloid-like fibrils when incubated under conditions similar to
those where BlaP(Gln)55 does not [18]. This observation suggests
that steric/conformational constraints imposed on the polyQ tract
in myoglobin are lower than those in BlaP. These lower
constraints could, at least in part, originate from the fact that (i)
the structure of myoglobin is perturbed by the insertion of the
polyQ tract while the structure of BlaP is not and (ii) the loop in
which the polyQ tract is inserted is significantly longer in
myoglobin than in BlaP, essentially due to the addition of several
amino acids from ataxin-3 at both sides of the polyQ tract [37]. In
the case of apomyoglobin, the insertion of 38Q, the longest tract
used in the aggregation studies, does not induce amyloid-like fibril
formation. This observation suggests that a 38Q tract inserted into
apomyoglobin is not long enough to access amyloid-competent
conformations and/or to overcome the steric hindrances exerted
by apomyoglobin.
Under native conditions, traces of dimeric species are observed
for both BlaP and all chimeras with the highest amount being
observed for wild-type BlaP (Table 1) which does not form
amyloid-like fibrils. It is therefore very unlikely that the observed
dimers act as seeds to facilitate fibril formation by BlaP(Gln)79 but
not, for example, BlaP(Gln)55. The high molecular weight
oligomeric species are however observed only for BlaP(Gln)79;
since this protein is the only one to aggregate into amyloid-like
fibrils under native conditions, the observed oligomers could
indeed act as seeds of fibril formation and thus accelerate the
process. A deeper characterization of the structural properties of
the oligomeric species and of their role in the process of
aggregation is under investigation. The potential of these species
to act as seeds does not, however, invalidate the conclusions of the
work. Indeed, this would purely imply that the constraints applied
by the BlaP moiety act to prevent the formation of amyloid-like
fibrils, at least in part, by preventing the formation of oligomeric
species that are formed early on the pathway of aggregation.
Conclusions
We have created and characterized a series of chimeras with 23,
30, 55 and 79 glutamines inserted into a solvent-exposed loop of a
globular protein, the b-lactamase BlaP. The threshold number of
glutamines above which the BlaP chimeras aggregate into
amyloid-like fibrils critically depends on the structural integrity
of the b-lactamase moiety. This result suggests that this threshold
value results, at least in part, from a delicate balance between the
intrinsic propensity of polyQ tracts to aggregate and the extrinsic
protective conformational/steric constraints originating from
BlaP. While it has been suggested that, in proteins associated
with diseases, polyQ tracts are located in regions that are
essentially unstructured and generally N- or C-terminal to a
structured domain [35], several studies have shown that sequences
flanking the polyQ tract could, however, adopt some elements of
secondary structure [30,55]. The latter could therefore exert
constraints on the polyQ tract similar to those exerted by the BlaP
moiety. The threshold for amyloid-like fibril formation by the BlaP
chimeras under native conditions (.55Q) is higher than the
highest threshold length observed for proteins associated with
diseases (49 residues in atrophin-1, [5]). This observation suggests
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state are higher than those imposed by the proteins associated with
polyQ diseases, probably because BlaP is a more structured and
rigid scaffold. The use of this globular protein has however allowed
us to produce and characterize, for the first time, a model protein
with an inserted 79Q tract. Interestingly, our results clearly show
that the structural integrity of BlaP, and thus the constraints
imposed on such a long tract, has negligible impact on the
propensity of the latter to mediate amyloid-like fibril formation.
Based on these observations, we speculate that the modulating
effects of the protein context on the aggregating properties of
proteins associated with polyQ diseases could also be negligible
when a particularly long polyQ tract is present. PolyQ tracts of 88–
306 residues were reported for some proteins associated with polyQ
diseases [1]; the aggregating properties of proteins with such long
tracts could be, therefore, dictated essentially by the intrinsic
propensity of the polyQ expansion to form intermolecular b-sheets.
Finally, this study demonstrates that BlaP is an appropriate
scaffold to further investigate the delicate balance between the
propensity of polyQ tracts to trigger aggregation and the
modulating effects of the host proteins.
Materials and Methods
Molecular biology
A library of (CAG)n double-strand DNA fragments was
constructed by an overlapping PCR strategy [56], using the
following oligonucleotides: 59-(CAG)13-39 and 59-(CTG)13-39.A
PCR using Pfu DNA polymerase (Promega, Madison, WI, USA)
was performed as follows: 3 min at 95uC, 30 sec at 94uC, 1 min at
55uC and 30 sec at 68uC; the last three steps were repeated 35
times. The library was purified from a 2% agarose gel and the
extremities of each double-strand DNA fragment were blunt-
ended with Pfu DNA polymerase and dNTPs at 68uC over a
period of 30 min. The polyCAG DNA fragments were then
dephosphorylated for 30 min at 37uC using calf intestinal alkaline
phosphatase (Roche, Manheim, Germany). Finally, the polyCAG
double-strand DNA library was inserted into the SmaI restriction
site, which was previously introduced in the gene of BlaP carried
by the constitutive expression vector pNYESBlaP [44]. In this
vector, the gene of BlaP is followed by the nucleotide sequence
coding for an additional C-terminal dipeptide glycine-proline and
a (His)5 tag. The resulting library of expression vectors was used to
transform E. coli DH5a cells (Invitrogen, Paisley, UK). Note that
the b-lactamase activity which enables E. coli to become resistant
to antibiotics can be used as a reporter to efficiently select clones
producing soluble chimeras in which BlaP is correctly folded.
Consequently, the transformed cells were plated on LB (Luria-
Bertani) medium containing ampicillin (10 mg?mL
21, Sigma) in
addition to spectinomycin (75 mg?mL
21, Sigma) for which the
plasmid contains a resistance gene. The presence of an insert
within the BlaP gene was checked by colony-PCR on more than
50 randomly selected transformants, and plasmids from about 10
colonies carrying an insertion were amplified and extracted. Their
sequences were determined by the Sanger method at the GIGA
GenoTranscriptomics technology platform (Lie `ge, Belgium).
Protein expression and purification
The proteins were expressed in E. coli JM109 strains (Promega).
A 100 mL LB medium preculture, containing 75 mg?mL
21 of
spectinomycin and 10 mg?mL
21 of ampicillin, was inoculated with
the transformed cells and incubated at 37uC for approximately
7 hours. Two liters of modified TB (Terrific Broth) medium
containing no glycerol, but supplemented with 75 mg?mL
21 of
spectinomycin, 10 mg?mL
21 of ampicillin, 4.2 mM of biotin and
2.2 mM riboflavin, were inoculated with 5 mL of preculture and
incubated overnight at 37uC. Periplasmic proteins were then
extracted by osmotic shock as described by Vandevenne et al. [44].
The proteins of interest, which were expressed with a C-terminal
(His)5 tag, were purified in a single step by metal chelate affinity
chromatography, using a 20 mL Ni-PDC column (Affiland, Lie `ge,
Belgium). After loading the periplasmic extract, the column was
washed successively with 60 mL of: (i) PBS (50 mM sodium
phosphate, pH 7.5, containing 150 mM NaCl); (ii) PBS containing
2 M NaCl; (iii) PBS containing 10 mM imidazole. Proteins were
eluted with a linear imidazole gradient (0–300 mM) in PBS.
Enzymatically active fractions (probed with nitrocefin as the
substrate) containing more than 95% of the protein of interest [as
assessed by 15% (w/v) SDS-PAGE] were pooled. They were then
either dialyzed four times against 15 L of milliQ water, lyophilized
and stored at 4uC, or dialyzed two times against 15 L of PBS and
stored at 220uC.
Size-exclusion chromatography
A Superdex 200 GL 10/300 column (G.E. Healthcare,
Uppsala, Sweden) was equilibrated with PBS buffer, pH 7.5.
Solutions of BlaP and the four chimeras at 50 mM and 120 mM,
and a solution of the chimera with 79 glutamines at 10 mM, in
PBS, pH 7.5, were injected and eluted at a flow rate of
0.5 mL?min
21. Elution of protein was monitored by absorbance
measurements at 280 nm. The column was calibrated using 7
protein standards: hen egg white lysozyme (Belovo, Bastogne,
Belgium), chicken egg white albumin (Sigma, A2512), phosphor-
ylase B from rabbit muscle (Sigma, P6635), b-galactosidase from
E. coli (Sigma, 48275), aldolase from rabbit muscle (Sigma, A2714),
catalase from bovine liver (Sigma, C40) and thyroglobulin from
bovine thyroid (Sigma, T9145).
N-terminal sequencing and mass spectrometry
N-terminal sequencing was performed using the Edman
degradation procedure according to Han’s protocol [57]. The
molecular masses were determined using electrospray ionisation
quadrupole time-of-flight mass spectrometry (ESI-QTOF-MS) at
the GIGA proteomics platform (Lie `ge, Belgium). The percentage
of each species observed within the same sample injection run was
estimated from the centroid value of peak.
Quantification of the protein
The molar extinction coefficient (33000 M
21?cm
21 at 280 nm)
of BlaP was determined experimentally using the BCA assay from
Pierce (Rockford, IL, USA). This value was used for the
determination of the concentrations of both wild-type and
chimeric enzyme solutions.
Enzymatic activity measurements
Kinetic parameters were determined at 30uC with cephalothin
(Sigma C4520, 50–100 mM) as the substrate, in 50 mM sodium
phosphate buffer, pH 7, using a UVIKON 860 spectrophotometer
(Kontron Instrument, Zu ¨rich, Switzerland), as described by
Matagne et al. [43].
Fluorescence and circular dichroism measurements
Fluorescence data were acquired using either a Cary Eclipse
spectrofluorimeter equipped with a Peltier-controlled holder
(Varian, Mulgrave, Australia) or a LS50B spectrofluorimeter
(Perkin-Elmer, Norwalk, CT, USA) and a 1 cm pathlength cell.
CD measurements were performed on a Jasco J-810 spectropo-
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holder and using 1 mm and 1 cm pathlength cells for far-UV and
near-UV measurements, respectively.
Fluorescence and circular dichroism spectra of native
proteins
All spectra were recorded at 25uC in PBS, pH 7.5, using protein
concentrations of 4.6 mM for fluorescence and far-UV CD
measurements, and 20 mM for near-UV CD measurements. Five
fluorescence emission spectra were recorded in the 300–400 nm
range (lexc=295 nm, slitexc=2.5 nm, slitem=5 nm), at a rate of
600 nm?min
21 using the Cary Eclipse spectrofluorimeter, and
averaged. Twenty CD spectra were acquired at a rate of
50 nm?min
21, both in the far-UV (200–250 nm) and near-UV
(250–350 nm) regions, and averaged. The bandwidth and the
response time were 1 nm and 0.5 sec, respectively. All protein
spectra (fluorescence and CD) were corrected for the buffer
contribution.
Urea-induced unfolding experiments
Protein samples (4.6 mM) in PBS, pH 7.5, at various urea
concentrations (VWR BDH Prolabo, 0 to 5.5 M by 0.1 M
increments) were unfolded to equilibrium by incubation for ca.
16 h at 25uC. Unfolding was monitored by changes in intrinsic
fluorescence (lexc=295 nm, lem=323 nm, slitsexc/em=2.6 nm)
using the LS50B spectrofluorimeter, and in far-UV CD signal at
222 nm (bandwidth=1 nm, response=4 sec), as described previ-
ously [58]. The background of the solutions (PBS buffer+dena-
turant) was subtracted from the fluorescence and CD signals. Urea
concentrations were determined from the refractive index
measurements [59] using a R5000 refractometer from Atago
(Tokyo, Japan). Moreover, other protein samples were denatured
for 3 hours at 25uC in 5.5 M urea (under these conditions, all the
investigated proteins have been shown to be completely unfolded)
and renatured (for ca. 16 h) by dilution to different urea
concentrations (from 5.5 to 0.55 M). The reversibility of the
unfolding transitions was demonstrated by comparing the
fluorescence and CD signals recorded with these samples to those
obtained for the samples unfolded at similar urea concentrations.
Equilibrium unfolding curves were analyzed on the basis of a two-
state model (N U), as previously described [58,60,61,62].
Heat-induced unfolding
Heat-induced unfolding was monitored by the changes in the
intrinsic fluorescence intensity (lexc=295 nm, lem=323 nm,
slitsexc/em=5 nm) using the Cary Eclipse spectrofluorimeter, and
in far-UV CD signal at 222 nm (bandwidth=1 nm, respon-
se=4 sec). The protein concentration was 4.6 mM in PBS,
pH 7.5, and mineral oil was added on top of the samples to limit
solvent evaporation. The temperature was increased from 25 to
85–90uC at a rate of 0.5uC?min
21; the fluorescence and the CD
data were acquired every 0.5uC. The temperature in the cell was
measured with a PT200 thermocouple (IMPO Electronic, Olgod,
Denmark). The reversibility of the heat-induced unfolding was
assessed by monitoring the changes in the fluorescence and CD
signals upon cooling the sample down to 25uC at a rate of
0.5uC?min
21. Data were analyzed on the basis of a two-state
model (N U), as described by El Hajjaji et al. [63].
Aggregation kinetics
As e r i e so ft u b e sc o n t a i n i n g1 0 0mLo f1 1 0mM protein in
PBS, pH 7.5, containing 0.2% sodium azide, were incubated
either at 37uC in the absence of urea or at 25uCi nt h ep r e s e n c e
of 1.85 or 3.5 M urea. Airtight tubes (Multiply Safecup,
Sarstedt, Nu ¨mbrecht, Germany) were used to limit evaporation.
At selected times, one tube was removed and centrifuged for
50 min at 12000 rpm. The supernatant was used to determine
the quantity of soluble protein by absorbance measurements at
280 nm and the protein integrity was demonstrated by SDS-
PAGE analysis. Unless otherwise stated, the aggregation time-
courses were repeated three times with proteins originating
from different production and purification batches. For one of
the aggregation time-courses of each protein, aliquots of
samples at the initial (T0)a n de n d( T f) time-points were taken
(in triplicate) before centrifugation for thioflavin T (ThT)
fluorescence measurements; they were kept frozen until
analysis. Samples at Tf were also analyzed by transmission
electron microscopy.
Thioflavin T (ThT) fluorescence measurements
To 5 mL protein sample was added 1.5 mL of 10 mM sodium
phosphate buffer, 150 mM NaCl, 50 mM ThT (Sigma, T3516),
pH 7. Ten fluorescence emission spectra were recorded (using the
Cary Eclipse spectrofluorimeter) at 25uC with stirring in the 450–
600 nm range (lexc=440 nm, slitexc/em=5 nm) at a rate of
1200 nm?min
21, averaged, and corrected for the background
fluorescence of the ThT solution alone.
Transmission electron microscopy
Samples were left for 4 min on carbon-coated 400-mesh copper
grids, before being stained for 1 min with 2% uranyl acetate (w/v).
The grids were then washed once with 2% uranyl acetate and
finally, three times with milliQ water. Images were recorded on a
Philips CEM100 transmission electron microscope operating at
100 kV.
X-ray fibre diffraction
Fibril suspensions were centrifuged and the pellet subjected to
two washing cycles in milliQ water; between each cycle, the
suspension was centrifuged and the supernatant discarded in
order to remove any trace of soluble protein, buffer, or urea.
The fibrils were then aligned using a modification of the
stretchframe method as previously described [64]. X-ray
diffraction data were collected at room temperature for ca.
10 min on a Bruker AXS FR591 diffractometer with Cu Ka
radiation with a wavelength of 1.5418 A ˚ and equipped with a
MARDTB 345 mm image plate detector. The sample-to-
detector distance was 300 mm.
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